NVCR - NovoCure Ltd
13.04
-1.190 -9.126%
Share volume: 1,368,599
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$14.23
-1.19
-0.08%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 07-25-2024 | 10-30-2024 | 02-27-2025 | 04-24-2025 | 07-24-2025 | 10-30-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 1.121 B | 1.212 B | 1.222 B | 1.241 B | 1.249 B | 1.246 B | 1.361 B | 804.326 M | |
| Current Assets | 1.003 B | 1.093 B | 1.095 B | 1.107 B | 1.089 B | 1.083 B | 1.200 B | 646.731 M | |
| Inventories | 42.391 M | 40.442 M | 39.096 M | 35.086 M | 39.468 M | 40.211 M | 39.104 M | 41.111 M | |
| Other Current Assets | 21.479 M | 32.858 M | 25.437 M | 35.063 M | 34.043 M | 39.139 M | 39.500 M | 58.669 M | |
| Short Term Investments | 21.479 M | 32.858 M | 774.476 M | 796.106 M | 801.852 M | 761.901 M | 691.382 M | 354.126 M | |
| Total Receivables | 65.091 M | 64.703 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 870.147 M | 951.186 M | 185.422 M | 163.767 M | 127.279 M | 149.624 M | 342.119 M | 93.548 M | |
| Total Non-current Assets | 118.721 M | 119.334 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 70.828 M | 78.196 M | 73.251 M | 77.660 M | 79.599 M | 80.333 M | 79.976 M | 77.606 M | |
| Other Assets | 14.899 M | 12.062 M | 53.467 M | 56.549 M | 79.909 M | 82.243 M | 81.364 M | 79.989 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.121 B | 1.212 B | 1.222 B | 1.241 B | 1.249 B | 1.246 B | 1.361 B | 804.326 M | |
| Total liabilities | 762.074 M | 850.420 M | 861.205 M | 880.605 M | 886.851 M | 896.434 M | 1.020 B | 463.860 M | |
| Total current liabilities | 160.230 M | 169.178 M | 735.002 M | 756.376 M | 743.305 M | 749.634 M | 776.006 M | 223.228 M | |
| Accounts Payable | 84.316 M | 90.171 M | 91.319 M | 105.086 M | 95.086 M | 103.678 M | 118.922 M | 122.231 M | |
| Other liabilities | 6.584 M | 6.041 M | 21.162 M | 19.989 M | 40.328 M | 42.871 M | 42.701 M | 41.647 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 569.652 M | 653.470 M | 97.149 M | 97.300 M | 97.450 M | 97.609 M | 194.639 M | 195.047 M | |
| Other liabilities | 6.584 M | 6.041 M | 21.162 M | 19.989 M | 40.328 M | 42.871 M | 42.701 M | 41.647 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 359.355 M | 361.750 M | 360.781 M | 360.179 M | 361.958 M | 349.441 M | 341.333 M | 340.466 M | |
| Common stock | 107.266 M | 107.700 M | 1.454 B | 1.520 B | 1.555 B | 1.583 B | 1.613 B | 1.634 B | |
| Retained earnings | -1.024 B | -1.058 B | -1.088 B | -1.154 B | -1.188 B | -1.229 B | -1.266 B | -1.290 B |